HALL A
09 January 2025
HALL B
09 January 2025
Hall C (KSA 1)
09 January 2025
Hall D (UoS 1)
09 January 2025
Hall F (KSA 2)
09 January 2025
Hall G (UoS 2)
09 January 2025
Hall H (GCC Program)
09 January 2025
Clinical Pharmacy & Optimization of Health
Array Mohamed A. Saleh,
B.Pharm, M.Sc., Ph.D., Prof. of Pharmacology, Clinical Sciences Department, College of Medicine, University of Sharjah, | United Arab Emirates
B.Pharm, M.Sc., Ph.D., Prof. of Pharmacology, Clinical Sciences Department, College of Medicine, University of Sharjah,
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Clinical pharmacy services in Central and Eastern Europe
Dr. Kamila Urbanczyk,
MPharm, Clinical Pharmacy Specialist, Department of Clinical Pharmacology, Wroclaw Medical University, President, Polish Society of Clinical Pharmacy, | Poland
MPharm, Clinical Pharmacy Specialist, Department of Clinical Pharmacology, Wroclaw Medical University, President, Polish Society of Clinical Pharmacy,
Lectures by this speaker
Thursday, 2025-01-09
Clinical pharmacy services in Central and Eastern Europe
09:00 - 09:45
Wednesday, 2025-01-08
How clinical pharmacist can optimize drug therapy throughout a hospital stay? Introduction to Integrated Medicines Management
14:00 - 15:00
09:00 - 09:45
Optimizing Cardiovascular Health through SGLT2 Inhibitors: Unveiling Anti-Inflammatory Pathways and Cardiac Cell Repair
Prof. Mohamed A. Saleh,
B.Pharm, M.Sc., Ph.D., Prof. of Pharmacology, Clinical Sciences Department, College of Medicine, University of Sharjah, | United Arab Emirates
B.Pharm, M.Sc., Ph.D., Prof. of Pharmacology, Clinical Sciences Department, College of Medicine, University of Sharjah,
Sessions by this speaker
Thursday, 2025-01-09
Clinical Pharmacy & Optimization of Health
09:00 - 10:30
Lectures by this speaker
Thursday, 2025-01-09
Optimizing Cardiovascular Health through SGLT2 Inhibitors: Unveiling Anti-Inflammatory Pathways and Cardiac Cell Repair
09:45 - 10:30
09:45 - 10:30
Best Practices in Education & Drug Shortages
Prof. Albert Wertheimer, | PhD, MBA, Nova Southeastern University, Florida,| USA
Array Albert Wertheimer,
PhD, MBA, Nova Southeastern University, Florida, | USA
PhD, MBA, Nova Southeastern University, Florida, USA
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Thursday,
-
Thursday,
-
Educators’ Role and Best Practices in Promoting Integrity and Ethics in Medical Education
Dr. Mohamed Ahmed Eladl,
Head of the Foundation Year Program in Medical Colleges, University of Sharjah, UAE | United Arab Emirates
Head of the Foundation Year Program in Medical Colleges, University of Sharjah, UAE
Lectures by this speaker
Thursday, 2025-01-09
Educators’ Role and Best Practices in Promoting Integrity and Ethics in Medical Education
10:45 - 11:30
10:45 - 11:30
Drug Shortages; causes and possible Solutions
Prof. Albert Wertheimer, | PhD, MBA, Nova Southeastern University, Florida, | USA
Prof. Albert Wertheimer,
PhD, MBA, Nova Southeastern University, Florida, | USA
PhD, MBA, Nova Southeastern University, Florida, USA
Sessions by this speaker
Thursday, 2025-01-09
Best Practices in Education & Drug Shortages
10:45 - 12:15
Lectures by this speaker
Thursday, 2025-01-09
Drug Shortages; causes and possible Solutions
11:30 - 12:15
Tuesday, 2025-01-07
Pharmaceutical Patents; Intended Uses and Abuses
12:30 - 13:15
Wednesday, 2025-01-08
Getting your research published in an International Journal
11:30 - 12:30
11:30 - 12:15
Role of the Pharmacist in Drug Safety & Efficacy
Array Amany Tawfik,
MD, M.Sc., Associate Professor, Oakland University, William Beaumont School of Medicine, Eye Research Center (OUWB)/ERC, Michigan, | USA
MD, M.Sc., Associate Professor, Oakland University, William Beaumont School of Medicine, Eye Research Center (OUWB)/ERC, Michigan,
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Drug Safety and Availability: A Shared Responsibility
Prof. Abdulla Molokhia | PhD., Professor, Pharmaceutics, Egypt. | Egypt
Prof. Abdulla Molokhia
PhD., Professor, Pharmaceutics, Egypt. | Egypt
PhD., Professor, Pharmaceutics, Egypt.
Lectures by this speaker
Thursday, 2025-01-09
Drug Safety and Availability: A Shared Responsibility
09:00 - 09:45
Wednesday, 2025-01-08
Current Challenges to Drug Supply Chain
13:00 - 14:00
09:00 - 09:45
Role of clinical pharmacist in optimizing the management of immune checkpoint inhibitors ICIs toxicities and efficacy
Prof. Christophe Bardin
Pharm D, PhD, Head of Clinical Pharmacy Oncology & Haematology - Metabolic diseases Service de Pharmacie - GH Cochin AP-HP.Centre – Université de Paris, Vice President, ESOP, | France
Pharm D, PhD, Head of Clinical Pharmacy Oncology & Haematology - Metabolic diseases Service de Pharmacie - GH Cochin AP-HP.Centre – Université de Paris, Vice President, ESOP,
Lectures by this speaker
Wednesday, 2025-01-08
Therapeutic Drug Monitoring of Anticancer Drugs, practical guidelines
15:30 - 16:15
Thursday, 2025-01-09
Role of clinical pharmacist in optimizing the management of immune checkpoint inhibitors ICIs toxicities and efficacy
09:45 - 10:30
Tuesday, 2025-01-07
Pharmaceutical consultations in hematology: a serious opportunity for clinical pharmacist
11:00 - 12:00
09:45 - 10:30
New Perspectives in Education and Therapy
Array Nabil Sulaiman,
Emeritus Professor, College of Medicines, University of Sharjah, UAE | United Arab Emirates
Emeritus Professor, College of Medicines, University of Sharjah, UAE
Sessions by this speaker
Thursday,
-
Thursday,
-
Lectures by this speaker
Thursday,
-
Thursday,
-
The clinical pharmacologist as an expert recourse for antiviral treatment
Prof. Florian Lemaitre,
Pharm. D., Ph.D., Prof. of Pharmacology & Clinical Investigator, Secretary – IATDMCT, Rennes University Hospital & Clinical Investigation Center , Rennes, | France
Pharm. D., Ph.D., Prof. of Pharmacology & Clinical Investigator, Secretary – IATDMCT, Rennes University Hospital & Clinical Investigation Center , Rennes,
Sessions by this speaker
Wednesday, 2025-01-08
Challenges in Pharmacy Practice
09:00 - 10:30
Lectures by this speaker
Wednesday, 2025-01-08
How to deal with immunosuppressive drugs in solid organ transplant recipients: dosages, monitoring and targets
09:45 - 10:30
Thursday, 2025-01-09
The clinical pharmacologist as an expert recourse for antiviral treatment
10:45 - 11:30
Tuesday, 2025-01-07
Management of drug-drug interactions: prevention is better than cure
12:15 - 13:15
10:45 - 11:30
Competency Assurance Program (CAP); a structured peer teaching and learning at the COM, University of Sharjah (UOS)
Prof. Nabil Sulaiman,
Emeritus Professor, College of Medicines, University of Sharjah, UAE | United Arab Emirates
Emeritus Professor, College of Medicines, University of Sharjah, UAE
Sessions by this speaker
Thursday, 2025-01-09
New Perspectives in Education and Therapy
10:45 - 12:15
Wednesday, 2025-01-08
Innovation in Pharmacy Practice & Product Development
09:00 - 10:30
Lectures by this speaker
Tuesday, 2025-01-07
Enhancing the understanding and insights about patient safety in a climate of interprofessional education: A pre-post interventional study
12:30 - 13:15
Thursday, 2025-01-09
Competency Assurance Program (CAP); a structured peer teaching and learning at the COM, University of Sharjah (UOS)
11:30 - 12:15
11:30 - 12:15
Specialty Practice & Strategies for Clinical Pharmacists
Array Suzanne Newman,
BPharm, Grad Dip Hosp Pharm, ANZCAP Reg.(Generalist), MSHP, Member Projects Manager at AdPha, | Australia
BPharm, Grad Dip Hosp Pharm, ANZCAP Reg.(Generalist), MSHP, Member Projects Manager at AdPha,
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Thursday,
-
Strategies of clinical pharmacists in Neurology to improve appropriateness and decrease the clinical risk.
Dr. Emanuela Peila | Pharm. D., Secretary of European Society of Clinical Pharmacy, | Italy
Dr. Emanuela Peila
Pharm. D., Secretary of European Society of Clinical Pharmacy, | Italy
Pharm. D., Secretary of European Society of Clinical Pharmacy,
Lectures by this speaker
Wednesday, 2025-01-08
New Radiopharmaceuticals in therapy and the role of Clinical pharmacist in Nuclear Medicine
14:45 - 15:30
Thursday, 2025-01-09
Strategies of clinical pharmacists in Neurology to improve appropriateness and decrease the clinical risk.
12:30 - 13:15
Tuesday, 2025-01-07
Role of pharmacists in reconciliation of medications
12:00 - 13:00
12:30 - 13:15
Specialty Practice connecting Australia’s pharmacists
Dr. Suzanne Newman,
BPharm, Grad Dip Hosp Pharm, ANZCAP Reg.(Generalist), MSHP, Member Projects Manager at AdPha, | Australia
BPharm, Grad Dip Hosp Pharm, ANZCAP Reg.(Generalist), MSHP, Member Projects Manager at AdPha,
Sessions by this speaker
Thursday, 2025-01-09
Specialty Practice & Strategies for Clinical Pharmacists
12:30 - 14:00
Lectures by this speaker
Wednesday, 2025-01-08
Advanced pharmacy and new recognition pathways in Australia and New Zealand’
10:45 - 11:30
Thursday, 2025-01-09
Specialty Practice connecting Australia’s pharmacists
13:15 - 14:00
13:15 - 14:00
Research Development
Array Abdulmalik M. Alqarni,
MSc, PhD. , Department of pharmaceutical chemistry College of clinical pharmacy, Imam Abdulrahman Bin Faisal University Dammam, | Saudi Arabia
Dr. Abdulmalik Alqarni is a prominent academic at Imam Abdulrahman Bin Faisal University (IAU) in Saudi Arabia, where he serves as the Vice Dean for Academic Affairs at the College of Clinical Pharmacy. He specializes in pharmaceutical analysis, with a strong focus on metabolomics. Dr. Alqarni has made significant contributions to the field, particularly in the extraction, development, and analysis of various sample matrices. Additionally, he has been appointed as a pharmaceutical regulation consultant for several institutions, further demonstrating his expertise and influence in the pharmaceutical sector. His work reflects a commitment to advancing knowledge and practice in pharmaceutical sciences.
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Metabonomics: A Platform for Studying Drug Discovery and Development
Dr. Abdulmalik M. Alqarni,
MSc, PhD. , Department of pharmaceutical chemistry College of clinical pharmacy, Imam Abdulrahman Bin Faisal University Dammam, | Saudi Arabia
Dr. Abdulmalik Alqarni is a prominent academic at Imam Abdulrahman Bin Faisal University (IAU) in Saudi Arabia, where he serves as the Vice Dean for Academic Affairs at the College of Clinical Pharmacy. He specializes in pharmaceutical analysis, with a strong focus on metabolomics. Dr. Alqarni has made significant contributions to the field, particularly in the extraction, development, and analysis of various sample matrices. Additionally, he has been appointed as a pharmaceutical regulation consultant for several institutions, further demonstrating his expertise and influence in the pharmaceutical sector. His work reflects a commitment to advancing knowledge and practice in pharmaceutical sciences.
Sessions by this speaker
Thursday, 2025-01-09
Research Development
09:00 - 10:30
Lectures by this speaker
Thursday, 2025-01-09
Metabonomics: A Platform for Studying Drug Discovery and Development
09:00 - 09:45
09:00 - 09:45
Evaluation of Pancreatic Function by Comparing Insulin Sensitivity in Type 2 Diabetes Mellitus (T2DM) Patients: A Two-center Prospective Study
Dr. Nawal H. Alsubaie
Ph.D., M.Sc., B.Sc., Asst Prof, Clinical Pharmacist Diabetes Clinic, KAAUH, Dept Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University | Saudi Arabia
Dr. Nawal Alsubaie, currently assistant professor at the Department of Pharmacy practice, Collage of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. She is a clinical pharmacist endocrinologist in the ambulatory care (Diabetes clinic) at KAAUH. She was the clinical pharmacist in charge at PSMMC ambulatory care clinics. She had her MSc. In clinical pharmacy from UCL, London in 2012. Furthermore, she finished her PhD in clinical pharmacy (diabetes management) from DMU, Leicester, United Kingdom in 2020 and had also diabetes management certificate from ASHP in 2023.
Lectures by this speaker
Thursday, 2025-01-09
Evaluation of Pancreatic Function by Comparing Insulin Sensitivity in Type 2 Diabetes Mellitus (T2DM) Patients: A Two-center Prospective Study
09:45 - 10:30
09:45 - 10:30
Pharmacy Practice II
Array Aymen Ali Alqurain
B.Pharm., MPallC, DipLM, Ph.D. Assistant Professor of Clinical Pharmacology and therapeutics Department of Clinical Practice, College of Pharmacy Northern Border University | Saudi Arabia
Dr. Alqurain is an assistant professor of clinical pharmacology and therapeutics at the clinical practice department, college of pharmacy at Northern Boarder University. He worked as an assistant professor of clinical pharmacology and therapeutics in the pharmacy department at Mohammed Al-Mana College for Medical Sciences. He is qualified with degrees in pharmacy from Curtin University, palliative care from Flinders University, and pharmacology from the University of South Australia. He is licensed to practice as a consultant pharmacist in Saudi Arabia and as a researcher pharmacist in Australia. Dr. Alqurain had the opportunity to work in various clinical settings, including ICU, palliative care, geriatrics, and internal medicine. His focus is on the safe and effective use of medicines, medication safety, pharmacoepidemiology, pharmacokinetics, and pharmacogenetics. His focus is on enhancing drug therapy for vulnerable patients, like elderly or paediatric patients.
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Safeguarding Patient Confidentiality: An In-Depth Exploration of Privacy Practices in Saudi Arabian Community Pharmacies
Dr. Marwan Alrasheed | Pharm.D., Ph.D. Assistant Professor | Saudi Arabia
Dr. Marwan Alrasheed
Pharm.D., Ph.D. Assistant Professor | Saudi Arabia
Marwan A. Alrasheed, PharmD, PhD, earned his PharmD from King Saud University and his PhD in Health Outcomes from the University of Cincinnati. His research focuses on pharmacy practice, social pharmacy, and health outcomes. Marwan has worked on topics like adverse drug events and community pharmacy privacy and is involved in projects related to real-world evidence and patient reported outcomes.
Lectures by this speaker
Thursday, 2025-01-09
Safeguarding Patient Confidentiality: An In-Depth Exploration of Privacy Practices in Saudi Arabian Community Pharmacies
11:00 - 11:45
11:00 - 11:45
Transition of Care’s Outcomes in Saudi Arabia
Dr. Hayam Ali AlRasheed,
BS PHARM, Pharm.D., Ph.D. Assistant Professor, Pharmacy Practice Department, College of Pharmacy, Princess Nourah University, Riyadh, | Saudi Arabia
"Dr. Hayam AlRasheed, an Assistant Professor of Pharmacy Practice at the Princess Nourah bint Abdulrahman University, is a distinguished academician with a focus on Sociobehavioral, administrative, and outcome research. She holds a Doctor of Pharmacy (Pharm.D.) from MCPHS University and a Doctoral of Philosophy (Ph.D.) in Social and Administrative Pharmacy from Nova Southeastern University. With over three years of academic experience, Dr. Alrasheed is committed to teaching future pharmacists through innovative curriculum design and practical learning. Her research focuses on preventive therapy and medication management, and she has published various articles in peer-reviewed journals. In addition to her teaching and research, Dr. Alrasheed actively contributes to community outreach programs, advocating for medication safety and health literacy. Dr. AlRasheed's passion for education is palpable in her work. Her commitment to improving patient outcomes, coupled with her dedication to teaching, make her a respected figure in the pharmacy field. Her passion is a personal trait and a driving force behind her professional success."
Lectures by this speaker
Thursday, 2025-01-09
Transition of Care’s Outcomes in Saudi Arabia
11:45 - 12:30
11:45 - 12:30
Investigating Metformin Utilization and the Risk of Overdose in Relation to Renal Function; Cross-sectional Retrospective Study
Dr. Aymen Ali Alqurain
B.Pharm., MPallC, DipLM, Ph.D. Assistant Professor of Clinical Pharmacology and therapeutics Department of Clinical Practice, College of Pharmacy Northern Border University | Saudi Arabia
Dr. Alqurain is an assistant professor of clinical pharmacology and therapeutics at the clinical practice department, college of pharmacy at Northern Boarder University. He worked as an assistant professor of clinical pharmacology and therapeutics in the pharmacy department at Mohammed Al-Mana College for Medical Sciences. He is qualified with degrees in pharmacy from Curtin University, palliative care from Flinders University, and pharmacology from the University of South Australia. He is licensed to practice as a consultant pharmacist in Saudi Arabia and as a researcher pharmacist in Australia. Dr. Alqurain had the opportunity to work in various clinical settings, including ICU, palliative care, geriatrics, and internal medicine. His focus is on the safe and effective use of medicines, medication safety, pharmacoepidemiology, pharmacokinetics, and pharmacogenetics. His focus is on enhancing drug therapy for vulnerable patients, like elderly or paediatric patients.
Sessions by this speaker
Thursday, 2025-01-09
Pharmacy Practice II
11:00 - 13:30
Lectures by this speaker
Thursday, 2025-01-09
Investigating Metformin Utilization and the Risk of Overdose in Relation to Renal Function; Cross-sectional Retrospective Study
12:30 - 13:15
12:30 - 13:15
Colleage of Medicine Session 2
Tailoring Precision Medicine and Nutrition for Optimal Patient Care in Oncology
Prof. Maha Saber - Ayad
Clinical Sciences Department, College of Medicine, University of Sharjah, | United Arab Emirates
Prof. Maha is a Professor of Pharmacology, College of Medicine, University of Sharjah. She finished her MSc in Endocrinology and Diabetes, Queen Mary University, UK; and her MSc in Leadership in Health Profession Education, RCSI, Ireland. MSc and PhD in Pharmacology at Cairo University. She has been a Fellow of the Royal College of Physicians in Edinburgh since 2013. Her main research focuses on colorectal cancer and its relation to autophagy. She has many publications in high-ranked peer-reviewed journals and several book chapters. She obtained several grants and research awards, including Sheikh Hamdan Award, Aljalila, MBRU-AlMahmeed, and GSK grants.
Lectures by this speaker
Thursday, 2025-01-09
Tailoring Precision Medicine and Nutrition for Optimal Patient Care in Oncology
09:00 - 09:40
09:00 - 09:40
Knowledge and Preparedness of Pharmacists and Pharmacy Students in the UAE for Managing the Mpox Outbreak
Dr. Eman Abu-Gharbieh | Vice Dean | United Arab Emirates
Dr. Eman Abu-Gharbieh
Vice Dean | United Arab Emirates
Prof. Eman Abu-Gharbieh is the Vice Dean at the College of Medicine, University of Sharjah. She earned her PhD in Pharmacology and Toxicology from the University of Bologna, Italy, in 2004 and her Pharmacy degree from the University of Jordan. As an active researcher, she is a member of several national and international organizations, including the American Society for Pharmacology and Experimental Therapeutics (ASPET). She also participates in two research groups at the Research Institute for Medical & Health Sciences (RIMHS): the Environment and Cancer Research group and the Improving Health Care Delivery and Medicines group. Prof. Abu-Gharbieh is a senior collaborator with the Global Burden of Diseases (GBD), has secured numerous research grants, and has published over 140 articles in international peer-reviewed journals. Her work has been presented at many national and international conferences
Lectures by this speaker
Thursday, 2025-01-09
Knowledge and Preparedness of Pharmacists and Pharmacy Students in the UAE for Managing the Mpox Outbreak
09:40 - 10:20
09:40 - 10:20
Exploring the Possible Involvement of FOXP1 in Pancreatic β-cells function
Dr. Waseem El-huneidi | Professor of Biochemistry | United Arab Emirates
Dr. Waseem El-huneidi
Professor of Biochemistry | United Arab Emirates
Dr. Waseem El-Huneidi is a Professor of Biochemistry at the Collegeof Medicine, University of Sharjah. He earned his Ph.D. inbiochemistry from the University of Waterloo in Ontario, Canada, in2008. Since then, Dr. El-Huneidi has worked in academia in severalcountries, including Jordan, Saudi Arabia, and the UAE. His researchprimarily focuses on diabetes and cancer, specifically investigatingthe roles of novel genes as potential regulators in the development ofthese diseases. Additionally, he explores the therapeutic potential ofterpenoids as treatments for cancer and diabetes. Dr. El-Huneidi'swork provides valuable insights into biochemistry, disease pathology,and possible therapeutic strategies for these conditions.
Lectures by this speaker
Thursday, 2025-01-09
Exploring the Possible Involvement of FOXP1 in Pancreatic β-cells function
10:30 - 11:10
10:30 - 11:10
Unravelling the role of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis
Prof. Jalal Taneera | Associate Prof | United Arab Emirates
Prof. Jalal Taneera
Associate Prof | United Arab Emirates
Dr. Taneera received his Ph.D. degree in experimental endocrinology (2007) at Lund University – Sweden. The main focus of his Ph.D. was to study the ability of adult stem cells to trans-differentiate into pancreatic beta-cell as a cell therapy for diabetes. After his Ph.D. he joined the department of diabetes and endocrinology at Lund University for post-doctoral training and besides his post-doc study, he worked as a coordinator for the Human Islets Facility at Lund University Diabetes Center (LUDC). In 2010, he started a new position at LUDC as Research Scientist. His main focus is on genetic profiling of human pancreatic islets and the identification of novel genes that contribute to type 2 diabetes etiopathogenesis. Dr. Taneera has a level of Assistant prof., he published about 80 peer-reviewed papers in major journals such as Cell Metabolism, PNAS, Nature, and Human Molecular Genetics. Since Mars, 2016 Dr. Taneera is working as Associate Prof at the medical college at University of Sharjah.
Lectures by this speaker
Thursday, 2025-01-09
Unravelling the role of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis
11:10 - 11:50
11:10 - 11:50
Assessing Meningitis Knowledge and Vaccination Attitudes and Practices Among United Arab Emirates Parents
Dr. Hiba Jawdat Barqawi | Lecturer in the Department of Clinical Sciences | United Arab Emirates
Dr. Hiba Jawdat Barqawi
Lecturer in the Department of Clinical Sciences | United Arab Emirates
Hiba Jawdat Barqawi is a Lecturer in the Department of Clinical Sciences at the College of Medicine in the University of Sharjah, where she teaches Medical Microbiology to undergraduate students. She obtained her MPharm (Hons) Pharmacy degree from the University of Bath, UK and then pursued postgraduate studies in Infectious Disease Epidemiology at Imperial College, University of London, UK. She was the Winner of the University of Sharjah Annual Faculty Incentive Award (Teaching Category) in May 2023.
Lectures by this speaker
Thursday, 2025-01-09
Assessing Meningitis Knowledge and Vaccination Attitudes and Practices Among United Arab Emirates Parents
11:50 - 12:30
11:50 - 12:30
From Spice to Cure: Unveiling Saffron’s Therapeutic Potential in Cancer Treatment
Dr. Amr Amin
Department of Basic Medical Sciences, College of Medicine, University of Sharjah, UAE | United Arab Emirates
The focus of Amin’s lab is to unravel the cellular and molecularmechanisms of selected natural-based small molecules againstgastrointestinal cancers. Through utilizing various cellular & molecular,nanoparticles, bioinformatics, and metabolomics techniques Amin’slab investigate a variety of biomolecules aiming to introduce them aspotential drug targets. He secured ten patents at United States, Japanand Australia. The nature on Amin’s research is highly collaborative.Throughout his career, Amin’s collaboration’s network grewsignificantly to include over 400 international collaborators from topresearch institutions in the word including Harvard, Stanford, andOxford, to name a few. He supervised many PhD and MSc Theses. Hisgraduate students were recruited to Harvard, ETH Zurich, FREDHUTCHINSON CANCER CENTER and many other prestigious schools.Prof. Amin published about 150 research articles and invited reviewsin top peer-reviewed journals where his students are usually co-authors. Amin is an editorial member and guest editor of manyjournals. Amin’s work in academia has been recognized by multiplenational and international awards including the UAE Presidential“Khalifa Award for Education for University Professor Distinguished inScientific Research” of UAE, the “Shoman Award for Arab Researchers”and others.
Lectures by this speaker
Thursday, 2025-01-09
From Spice to Cure: Unveiling Saffron’s Therapeutic Potential in Cancer Treatment
12:40 - 13:20
12:40 - 13:20
Exploring the Expression and Role of the DEAD box protein DDX1 in Renal Cell Carcinoma
Prof. Iman Talaat | Professor and a Consultant Anatomic Pathologist | United Arab Emirates
Prof. Iman Talaat
Professor and a Consultant Anatomic Pathologist | United Arab Emirates
Prof. Iman M. Talaat is a Professor and a Consultant Anatomic Pathologist at the Clinical Sciences Department, College of Medicine, University of Sharjah. She earned an MSc and a PhD/MD in Anatomic Pathology from the Faculty of Medicine, Alexandria University, Egypt. She specializes in surgical and molecular pathology, focusing on cancer research, mainly solid tumors and the pathogenesis of different neoplastic and non-neoplastic diseases. She is the coordinator of the “Immuno-oncology” research group at the Research Institute for Medical and Health Sciences (RIMHS) at the University of Sharjah, which focuses on understanding the cancer microenvironment and, in particular, the crosstalk between immune and tumor cells, as well as the epigenetic regulation of carcinogenesis. Additionally, she is a member of the Bioinformatics and Functional Genomics research group and the co-director of the Sharjah Tissue Biobank at the RIMHS. Moreover, she is a member of several scientific societies, such as the American Society for Investigative Pathology, the European Association of Cancer Research, the American Society for Clinical Pathology, and the Digital Pathology Association. She has over 100 publications in high-impact peer-reviewed journals and is the PI and co-PI of various internal and external grants.
Lectures by this speaker
Thursday, 2025-01-09
Exploring the Expression and Role of the DEAD box protein DDX1 in Renal Cell Carcinoma
13:20 - 14:00
13:20 - 14:00
Clinical Pharmacy II
Array Mohammed Ali Aseeri
i, PharmD, BCPS, FISMP Director, Pharmaceutical Care Services Associate Professor of Pharmacy Practice | Saudi Arabia
Dr. Aseeri is currently the director pf pharmaceutical care services at King Abdul Aziz Medical in Jeddah and associate professor at the college of medicine at King Saud bin Abdulaziz University for health Sciences. He obtained his bachelor degree in pharmacy in 2000 from King Saud University and pharmacy doctor degree from North Dakota States University in 2006. He completed a residency training in 2007 from Wesley medical center and a fellowship in safe medication management at Institute for Safe medication practices (ISMP) in 2012.
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Optimizing Treatment Strategies for Diabetic Nephropathy: A Pathway to Managing Chronic Kidney Disease
Dr. Mohamed Abdulrahman Albekery
Pharm.D., SSC-PhP, ASHP-PhP, SSC-Nep Assistant Professor of Nephrology | Saudi Arabia
"Dr. Mohamed A. Albekery is an Assistant Professor of Nephrology Pharmacotherapy in the Department of Pharmacy Practice at the College of Clinical Pharmacy, King Faisal University, and serves as a Nephrology Clinical Pharmacy Specialist at the National Guard Health Affairs in AlAhsa, Saudi Arabia. Dr. Albekery completed his Pharm.D. at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in 2017. His postgraduate studies include a PGY-1 residency accredited by both the Saudi Commission for Health Specialties (SCFHS) and the American Society of Health System Pharmacists (ASHP), and a PGY-2 in Nephrology at King Abdulaziz Medical City in 2020. Additionally, he holds an ASHP teaching certificate and a Training of Trainers certificate from SCFHS. He actively publishes in nephrology-focused peer-reviewed journals and has presented on various nephrology-related topics at multiple conferences. Dr. Albekery is also a Surveyor for SCFHS training program and center accreditations and is a member of several committees.
Lectures by this speaker
Thursday, 2025-01-09
Optimizing Treatment Strategies for Diabetic Nephropathy: A Pathway to Managing Chronic Kidney Disease
09:00 - 09:45
09:00 - 09:45
Real-World Comparison of Health-related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients
Dr. Miteb A. Alanazi,
M.Sc. (Pharm.), Hematology, Oncology Pediatric Clinical Pharmacist Drug & Poison Information Center, Adj Clinical Asst. Prof. King Saud University Medical City, | Saudi Arabia
Miteb Alanazi is a senior pediatric oncology clinical pharmacist at King Saud University Medical City. He started his career in the pharmacy field since 2003. Dr. Miteb earned his master degree in clinical pharmacy from the pharmacy college at King Saud University. He acted as out-patient pharmacy assistant director from 2011-2015. Also, he was the director of pharmacy research center and toxicology lab from 2011-2013. Dr. Miteb is an active member of many professional societies such as “Saudi Oncology Pharmacy Assembly”, “American Association of College of Pharmacy”, and “Saudi Pharmaceutical Society”. Additionally, Dr. Miteb is the co-chair for the Vaccine Advisory Committee at King Saud University Medical City. Beside his professional duties, Dr. Miteb is participating in teaching and training numerous courses and students from different colleges of pharmacy.
Lectures by this speaker
Thursday, 2025-01-09
Real-World Comparison of Health-related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients
09:45 - 10:30
09:45 - 10:30
Clinical Pharmacy III
Dr. Mohammed Al Essa | Associate Professor| Saudi Arabia
Array Mohammed Al Essa
Associate Professor | Saudi Arabia
Dr. Mohammed Alessa graduated with a Bachelor’s Degree in Pharmaceutical Sciences from king Saud University, Riyadh, KSA in 2009. He then received his Doctor of Pharmacy Degree (PharmD) from Massachusetts College of Pharmacy and Health Sciences University, USA in 2013. After that, he completed his PGY-1 Pharmacy Practice Residency and PGY-2 Internal Medicine Pharmacy Residency at Midtown Medical Center, Columbus, GA, USA in 2014-2015 (both are ASHP-accredited). Additionally, he is a Board-Certified Pharmacotherapy Specialist. He is an Associate Professor of Clinical Pharmacy at College of Pharmacy, King Saud University and a Clinical Pharmacy Specialist, Internal Medicine at King Saud University Medical City, Riyadh, KSA. In addition, he is the chairman of pharmacy residency programs council at King Saud University Medical City. His research interests are focused on clinical pharmacy practice, internal medicine, infectious diseases, and academia, and he had multiple publications.
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Randomized Controlled Trial on Optimizing Community Pharmacist’s Care for the Elderly: The Influence of WhatsApp-Email delivered Clinical Case Scenarios
Dr. Yousef Saeed Alqarni
Pharm.D., M.Sc., Ph.D. Assistant Professor, Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University | Saudi Arabia
Dr. Yousef Alqarni, PharmD., MS., Ph.D. Assistant Professor at Pharmacy Practice Department, 2023 PhD in pharmaceutical science (Sociobehavioral & administrative pharmacy) Nova Southeastern University Fort Lauderdale, USA 2019 Master in pharmaceutical science (Pharmacy administration) Saint Joseph's University Philadelphia city, USA
Lectures by this speaker
Thursday, 2025-01-09
Randomized Controlled Trial on Optimizing Community Pharmacist’s Care for the Elderly: The Influence of WhatsApp-Email delivered Clinical Case Scenarios
11:00 - 11:45
11:00 - 11:45
Anticholinergic Prescribing Among Older Patients Attended an Emergency Department
Dr. Afnan Saad Alshnbari
Ph.D., Assistance professor of Pharmacology Department of Pharmacy Mohammed Al-mana College for Medical Sciences Dammam, | Saudi Arabia
Dr. Afnan Saad Alshnbari is a registered pharmacist with a PhD in Clinical and Experimental Pharmacology from the University of Nottingham, UK. She currently serves as an Assistant Professor at Mohammed Al-Mana College for Medical Sciences, where she instructs students in pharmacology, evidence-based medicine, and another subject in pharmacy. Additionally, she holds the position of chair on patents and intellectual properties and leads initiatives for intellectual awareness. Dr. Alshnbari has a strong research background, particularly in the cardiorenal protection of SGLT2 inhibitors in diabetes, with multiple publications and conference presentations. She is passionate about combining teaching, research, and public engagement in health education.
Lectures by this speaker
Thursday, 2025-01-09
Anticholinergic Prescribing Among Older Patients Attended an Emergency Department
11:45 - 12:30
11:45 - 12:30
Impact of Glucagon-like peptide 1 Receptor Agonist (GLP1RA) on Respiratory Disease Exacerbation: A Retrospective Study
Dr. Sawsan Kurdi
PharmD, BC-ADM, FHEA, Asst. Prof Pharmacy Practice, Ambulatory Care Clinical Pharmacist, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University | Saudi Arabia
Dr. Kurdi is an Ambulatory care clinical pharmacist. She is an Assistant professor and the head of the pharmacy practice department at the college of clinical pharmacy in Imam Abdulrahmam bin Faisal University in Dammam. She earned her PharmD from King Abdulaziz University in Jeddah. she then earned her PGY1 from Massachusetts general hospital in Boston and her PGY2 and fellowship in ambulatory care from university of Arizona.
Lectures by this speaker
Thursday, 2025-01-09
Impact of Glucagon-like peptide 1 Receptor Agonist (GLP1RA) on Respiratory Disease Exacerbation: A Retrospective Study
12:30 - 13:15
12:30 - 13:15
Medical Sciences (UoS)
The quest for biomarkers in stroke: Thrombospondin-1 as a predictor of stroke outcome
Prof. Ahmed Alhusban | Doctor of Pharmacy Degree | United Arab Emirates
Prof. Ahmed Alhusban
Doctor of Pharmacy Degree | United Arab Emirates
Dr. Alhusban Obtained his Doctor of Pharmacy Degree from the Jordan University of Science and Technology and joined the University of Georgia-US to obtain his Ph.D. in Clinical andExperimental Therapeutics. He then joined the JUST as an Assistant Professor at the Department of Clinical Pharmacy. His research is focused on understanding the mechanisms by which diabetes and hyperlipidemia impair the neuroprotective effect of endothelial cellsafter stroke at the preclinical level. Additionally, Dr. Alhusban has a special interest in the use of virtual reality in education. Currently, heis holding an associate professor position at the university of Sharjah. Title of the topic: The quest for biomarkers in stroke: Thrombospondin-1 as a predictorof stroke outcome.
Lectures by this speaker
Thursday, 2025-01-09
The quest for biomarkers in stroke: Thrombospondin-1 as a predictor of stroke outcome
09:00 - 09:40
09:00 - 09:40
Antitumor Activity of Algae-Derived Silver Nanoparticles Against Human Triple-Negative Breast Cancer Cells
Dr. Khalid Bajou
Associate Professor, Department of Applied Biology, College of Sciences, | United Arab Emirates
Dr. Khalid Bajou is an Associate Professor in the Department of Applied Biology at the College of Sciences, University of Sharjah. He earned his Ph.D. from the University of Liège, Belgium, in 2001. After completing his doctorate, Dr. Bajou conducted five years of postdoctoral research at the University of Southern California, Los Angeles. Before joining the University of Sharjah in 2015, he held a faculty position as Assistant Professor at the University of Liège. Dr. Bajou’s research is primarily focused on Cancer Biology, particularly on the tumor microenvironment. His work investigates the pathological roles of the fibrinolytic system in angiogenesis and metastasis, with the aim of developing of new cancer therapies.
Lectures by this speaker
Thursday, 2025-01-09
Antitumor Activity of Algae-Derived Silver Nanoparticles Against Human Triple-Negative Breast Cancer Cells
09:40 - 10:20
09:40 - 10:20
AI-Driven Virtual Screening Reveals a Novel Dual-Action Anti-SARS-CoV-2 Compound with Superior Antiviral Efficacy
Dr. Ahmed Almehdi | Associate Professor | United Arab Emirates
Dr. Ahmed Almehdi
Associate Professor | United Arab Emirates
Dr. Ahmed M. Almehdi is an Associate Professor at the University of Sharjah, UAE, specializing in Biochemistry with a focus on protein biochemistry and biosynthesis. He holds a Ph.D. from Oregon State University and has extensive experience in research areas such as biochemical enzymology, toxicology of bioactive natural products, metallomics, and redox coenzymes. Dr. Almehdi has held several academic leadership roles, including Manager of the Students Study Abroad Unit and Team Leader for the Students Exchange Program. His research interests span the biochemical effects of natural products and metals, particularly in the fields of cancer, diabetes, and antimicrobial activity. Dr. Almehdi has been recognized for his scientific contributions, having authored numerous peer-reviewed publications and patents, including innovative work on dual inhibitors for SARS-CoV-2. He has also been awarded multiple service excellence awards for his contributions to academic and community service.
Lectures by this speaker
Thursday, 2025-01-09
AI-Driven Virtual Screening Reveals a Novel Dual-Action Anti-SARS-CoV-2 Compound with Superior Antiviral Efficacy
10:20 - 11:00
10:20 - 11:00
Medical and Pharmaceutical Sciences (UoS)
Metabolism-Centric Strategies for the Design of Novel Antimicrobials and Adjuvants
Dr. Sameh Soliman
Associate professor of Medicinal Chemistry and Infectious diseases Research Group Coordinator | United Arab Emirates
Dr. Sameh Soliman has obtained his bachelor’s and master’s degrees in pharmaceutical sciences. He received his PhD from University of Guelph, Canada in chemical ecology of natural metabolites and its role in host-microbe interactions. Then he did a Postdoctoral fellowship in mycotoxin manipulation and detoxification at Canadian Federal labs followed by another Postdoctoral fellow at UCLA in Chemical and biomolecular engineering of natural products. At UCLA Medical School, he has been trained on pathogenesis mechanisms in infectious diseases, and possible ways in diagnosis and treatment. Currently, he is an associate professor of Medicinal Chemistry and Infectious diseases Research Group Coordinator. Dr Soliman published more than 120 articles, several book chapters, and three patents, and received several awards. Several of these articles are published in Nature Microbiology, Nature Communication, Science Advances, Scientific Reports, Current Biology, and others. Dr. Soliman is leading projects in chemical ecology and metabolic dynamics in host- microbe interaction with a research focus on the discovery of microbial toxins, the identification of binding host receptors, signaling pathways, and mechanisms of immune evasion. His research includes the design and discovery of new antimicrobial drugs and drug re-sensitization to overcome resistance problems, the use of natural products and foods to manipulate and protect against microbial and viral infections, in addition to the development of diagnostic strategies.
Lectures by this speaker
Thursday, 2025-01-09
Metabolism-Centric Strategies for the Design of Novel Antimicrobials and Adjuvants
11:10 - 11:50
11:10 - 11:50
Untargeted Metabolomic Profiling of Gestational Diabetes Mellitus: Insights into Early Diagnosis and Metabolic Pathway Alterations
Dr. Shereen Aleidi | Associate professor | United Arab Emirates
Dr. Shereen Aleidi
Associate professor | United Arab Emirates
Dr. Shereen Aleidi is an Associate professor of biochemistry the college of Pharmacy, University of Sharjah. She obtained her PhD in pharmacy from the University of Sydney, Australia in 2016. Dr. Aleidi has been very productive and has published several papers in peer-reviewed highly qualified journals. Dr. Aleidi research area includes biomarker discovery and evaluation: unraveling hidden biomolecular signatures that could revolutionize diagnostics, prognostics, and personalized medicine. Multi-Omics (Metabolomics, lipidomics, and proteomics) analysis and clinical interpretation.
Lectures by this speaker
Thursday, 2025-01-09
Untargeted Metabolomic Profiling of Gestational Diabetes Mellitus: Insights into Early Diagnosis and Metabolic Pathway Alterations
11:50 - 12:30
11:50 - 12:30
Innovative Strategy to Overcome Multi-Drug Resistance: Design and Evaluation of Novel Compounds Targeting Hyphae Formation in Candida albicans
Dr. Rania Hamdy | Environmental and chemical biology research group | United Arab Emirates
Dr. Rania Hamdy
Environmental and chemical biology research group | United Arab Emirates
Dr. Rania Hamdy. She earned her bachelor's and master's degrees in pharmaceutical sciences from the Department of Medicinal Chemistry. She got her PhD through a channel program between Cardiff University in the United Kingdom and Zagazig University in Egypt. She then completed a research fellowship at Sharjah Institute of Medical Research SIMR in the infectious disease lab. Currently she joined the Environmental and chemical biology research group as a postdoc fellowship. She worked on lead optimization and drug design of innovative natural-based bioactive therapeutic candidates with a primary focus on antibacterial, antiviral, and anticancer research. She was trained in artificial intelligence and its applications in drug design and discovery, as well as synthetic organic chemistry. Her research focuses on identifying novel therapeutic targets involved in virulent pathogenic mechanisms and potential treatment approaches. Her research interests include also the design and synthesis of new small molecules that function as potential bioactive agents. She applied computational computer-based methodologies to the design of novel bioactive compounds, focusing on infectious disease. Her main goal is to accelerate the discovery of novel biologically active hits that may subsequently be optimized to prospective clinical candidates, which she accomplishes by integrating several approaches ranging from conventional medicinal chemistry to more modern computer-based procedures. Her patent and international publications, as well as the national and worldwide network of active collaborations she has created over the years, highlight the very interdisciplinary and collaborative nature of her research
Lectures by this speaker
Thursday, 2025-01-09
Innovative Strategy to Overcome Multi-Drug Resistance: Design and Evaluation of Novel Compounds Targeting Hyphae Formation in Candida albicans
12:30 - 13:10
12:30 - 13:10
Clinical Pharmacists’ Evaluation Of Drug-Related Problems In Intensive Care Unit: A Systemic Review.
Prof. Amna Othman | Pharmacist | United Arab Emirates
Prof. Amna Othman
Pharmacist | United Arab Emirates
Dr Amna Othman is a pharmacist with master’s degree in clinical drug development. She is currently a research assistant and clinical tutor at College of Pharmacy, University of Sharjah since 2018 to date. Her area of expertise is in pharmacy practice, health services, and clinical pharmacy research. Additionally, she provides significant assistance in teaching, tutoring, and organizing e-learning technologies, as well as in supporting PharmD students' training.
Lectures by this speaker
Thursday, 2025-01-09
Clinical Pharmacists’ Evaluation Of Drug-Related Problems In Intensive Care Unit: A Systemic Review.
13:10 - 13:50
13:10 - 13:50
Session 4 : GCC
Array Afrah Alkazemi, BPharm
PharmD, MSc. Clinical Pharm, BCPS, Assistant Professor, College of Pharmacy – Kuwait University, | Kuwait
Dr. Alkazemi is an assistant professor at Kuwait University's College of Pharmacy. She earned her Bachelor of Pharmacy from Kuwait University in 2008 and a Master of Science in Clinical Pharmacy, from University College London in 2014. Continuing her academic endeavors, Dr. Alkazemi furthered her education with a Doctor of Pharmacy (PharmD) degree from MCPHS University, Boston, USA, in 2018. She then completed an ASHP accredited Postgraduate Year 1 (PGY1) Pharmacy Residency at BIDMC Hospital, Boston, USA, in 2019. Dr. Alkazemi completed two clinical research pharmacy fellowships at Brigham and Women’s Hospital in Boston, USA. She finished a fellowship in Quality and Safety in 2020, followed by a fellowship in Critical Care in 2021. Dr. Alkazemi has experience in clinical practice within hospital settings, coupled with publications concentrated in the realm of critical care. She has interest in ECMO-related pharmacokinetic alterations of medications, TDM, anticoagulation management in addition to education on ECMO-related pharmacotherapy principles. "
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
Home TPN: Importance and Challenges in Kuwait compared to other countries
Dr. Ali Abdullah, | MPharm, MSc, Senior Pharmacist, Mubarak Al-Kabeer Hospital, | Kuwait
Dr. Ali Abdullah,
MPharm, MSc, Senior Pharmacist, Mubarak Al-Kabeer Hospital, | Kuwait
"RPh. Ali Abdullah is the head of Total parenteral nutrition unit in the Pharmacy Department of Mubarak Al-Kabeer hospital. Mubarak Al-Kabeer hospital is considered as one of the biggest and major hospitals in Kuwait which serves a population of no less than 250,000. He leaded some teams within the department such as participating in the scientific and the quality control teams. RPh. Abdullah is also a visiting teaching assistant in the Pharmaceutical Science department in College of Health Science in Public Authority of Applied Education and Training. Alongside, RPh. Abdullah contributed in editing the 200 Common Drugs of Kuwait Booklet which is the most recent medicines references in Kuwait. Moreover, he also contributed in authoring in several articles in collaboration with Kuwait university. RPh. Abdullah graduated with MSc from Kings college of London which is one of the most distinguished schools of pharmacy worldwide."
Lectures by this speaker
Thursday, 2025-01-09
Home TPN: Importance and Challenges in Kuwait compared to other countries
09:00 - 09:45
09:00 - 09:45
Navigating Discontinuation Syndrome: Clinical Strategies for Recognition and Treatment
Dr. Afrah Alkazemi, BPharm
PharmD, MSc. Clinical Pharm, BCPS, Assistant Professor, College of Pharmacy – Kuwait University, | Kuwait
Dr. Alkazemi is an assistant professor at Kuwait University's College of Pharmacy. She earned her Bachelor of Pharmacy from Kuwait University in 2008 and a Master of Science in Clinical Pharmacy, from University College London in 2014. Continuing her academic endeavors, Dr. Alkazemi furthered her education with a Doctor of Pharmacy (PharmD) degree from MCPHS University, Boston, USA, in 2018. She then completed an ASHP accredited Postgraduate Year 1 (PGY1) Pharmacy Residency at BIDMC Hospital, Boston, USA, in 2019. Dr. Alkazemi completed two clinical research pharmacy fellowships at Brigham and Women’s Hospital in Boston, USA. She finished a fellowship in Quality and Safety in 2020, followed by a fellowship in Critical Care in 2021. Dr. Alkazemi has experience in clinical practice within hospital settings, coupled with publications concentrated in the realm of critical care. She has interest in ECMO-related pharmacokinetic alterations of medications, TDM, anticoagulation management in addition to education on ECMO-related pharmacotherapy principles. "
Sessions by this speaker
Thursday, 2025-01-09
Session 4 : GCC
09:00 - 11:15
Lectures by this speaker
Thursday, 2025-01-09
Navigating Discontinuation Syndrome: Clinical Strategies for Recognition and Treatment
09:45 - 10:30
09:45 - 10:30
Designing Effective Pharmacist-Led Clinics for Chronic Disease Management: Key Components and Strategies
Dr. Arwa Khalifah Alfraij, | B.Pharm, Pharm.D, clinical pharmacist, Fnaitess Medical Center | Kuwait
Dr. Arwa Khalifah Alfraij,
B.Pharm, Pharm.D, clinical pharmacist, Fnaitess Medical Center | Kuwait
"Dr. Arwa Alfraij is a clinical pharmacist graduated from the College of Pharmacy with a Bachelor of Pharmacy Degree, Academic year 2017, and completed the Add-on PharmD Program at the College of Pharmacy, Kuwait University, Academic Year 2018-2019. Oct, 2019 started the clinical role as clinical pharmacist in internal medicine ward, Mubarak Al-Kabeer Hospital (MKH) covering both Male and Female sides. In 2022/2023 worked as Clinical Tutor for Pre-Grad. PharmD student, Collage of Pharmacy, Kuwait University. Current position is in Fnaitess Medical Center working on a new service which is Establishing medication reconciliation clinic run by clinical pharmacist. My Area of interest is in Chronic disease management working in collaboration with doctors, nurses and dietitian as multidisciplinary team. this will lead to effective medication therapy management and reducing medication errors. "
Lectures by this speaker
Thursday, 2025-01-09
Designing Effective Pharmacist-Led Clinics for Chronic Disease Management: Key Components and Strategies
10:30 - 11:15
10:30 - 11:15
Session 5 : GCC
Array Maryam Alobaidly,
PharmD., MSc., BCPS, Assistant Professor at the Department of Pharmacy Practice, Kuwait University | Kuwait
"Dr. Maryam AlObaidly received her Bachelor of Pharmacy from the Royal College of Surgeons, Dublin, Ireland followed by a Masters's degree in Molecular and Cellular Therapy in platelet activation during pregnancy at the Royal College of Surgeons, Dublin, Ireland while practicing as a pharmacy intern in a private pharmacy. She briefly served as a pharmacist in specialized polyclinics (Qurtoba and AlSaqer) and public hospitals (AlAdan and Mubarak AlKabeer). She then joined Massachusetts College of Pharmacy and Health Sciences University to receive her Doctor of Pharmacy degree. She completed her post-doctoral at the Department of Quality and Safety where she also received her Institute for Healthcare Improvement certificate, followed by completing her pharmacy practice residency PGY-1 and PGY-2 in Solid Organ Transplantation at Brigham and Women’s Hospital, Boston, MA, USA where she completed her Teaching and Learning Certificate. Dr. AlObaidly is credentialed by the Board of Pharmaceutical Specialties (BPS) as a Board Certified Pharmacotherapy Specialist. Dr. AlObaidly joined the Pharmacy College at Kuwait University in 2023 as an Assistant Clinical Professor where she is responsible for coordinating modules, precepting students in class and during rotations advancing their role as future pharmacists, giving didactic lectures, and helping students make the connection between required knowledge and virtual clinical experience. She also practices as a clinical pharmacist in Sheikha Badriya Al-Ahmed Al-Jaber Al-Sabah Center for Oncology and Stem Cell Transfusion."
Sessions by this speaker
Thursday,
-
Lectures by this speaker
Thursday,
-
GLP-1 Receptor Agonists: Past, Present, and Future
Dr. Bader Alrashidi, | PharmD, MPH, Clinical Pharmacist - Mubarak Al-Kabeer Hospital | Kuwait
Dr. Bader Alrashidi,
PharmD, MPH, Clinical Pharmacist - Mubarak Al-Kabeer Hospital | Kuwait
Bader Alrashidi is a dedicated clinical pharmacist skilled in optimizing patient care through clinical interventions and medication therapy management. Proficient in Arabic and English, he brings strong leadership, problem-solving, and event planning skills to his roles. Education: MPH (Expected 2025) - Kuwait University (Health Policies & Management) PharmD - Kuwait University, 2022 BPharm - Kuwait University, 2019 Diploma in Computer Engineering - 2009 Experience: Clinical Pharmacist - Mubarak Al-Kabeer Hospital (2023 - Present) Leads quality initiatives, collaborates on patient education, and provides clinical guidance. Hospital Pharmacist - Mubarak Al-Kabeer & Jaber Al Ahmad Hospitals (2019 - 2023) Oversaw pharmacy operations, managed inventory, and supported emergency services. Affiliations: KPAC Committee Member (2023-2024) KUPHA Scientific and Cultural Committee (2022-2024) COVID-19 Volunteer - 2020 Skills: Microsoft Office, Endnote, STATA; effective communicator with proven leadership abilities."
Lectures by this speaker
Thursday, 2025-01-09
GLP-1 Receptor Agonists: Past, Present, and Future
11:30 - 12:15
11:30 - 12:15
Atrial Fibrillation Post-Lung Transplantation
Dr. Maryam Alobaidly,
PharmD., MSc., BCPS, Assistant Professor at the Department of Pharmacy Practice, Kuwait University | Kuwait
"Dr. Maryam AlObaidly received her Bachelor of Pharmacy from the Royal College of Surgeons, Dublin, Ireland followed by a Masters's degree in Molecular and Cellular Therapy in platelet activation during pregnancy at the Royal College of Surgeons, Dublin, Ireland while practicing as a pharmacy intern in a private pharmacy. She briefly served as a pharmacist in specialized polyclinics (Qurtoba and AlSaqer) and public hospitals (AlAdan and Mubarak AlKabeer). She then joined Massachusetts College of Pharmacy and Health Sciences University to receive her Doctor of Pharmacy degree. She completed her post-doctoral at the Department of Quality and Safety where she also received her Institute for Healthcare Improvement certificate, followed by completing her pharmacy practice residency PGY-1 and PGY-2 in Solid Organ Transplantation at Brigham and Women’s Hospital, Boston, MA, USA where she completed her Teaching and Learning Certificate. Dr. AlObaidly is credentialed by the Board of Pharmaceutical Specialties (BPS) as a Board Certified Pharmacotherapy Specialist. Dr. AlObaidly joined the Pharmacy College at Kuwait University in 2023 as an Assistant Clinical Professor where she is responsible for coordinating modules, precepting students in class and during rotations advancing their role as future pharmacists, giving didactic lectures, and helping students make the connection between required knowledge and virtual clinical experience. She also practices as a clinical pharmacist in Sheikha Badriya Al-Ahmed Al-Jaber Al-Sabah Center for Oncology and Stem Cell Transfusion."
Sessions by this speaker
Thursday, 2025-01-09
Session 5 : GCC
11:30 - 13:45
Lectures by this speaker
Thursday, 2025-01-09
Atrial Fibrillation Post-Lung Transplantation
12:15 - 13:00
12:15 - 13:00
A qualitative study exploring patients’ experiences regarding insulin pump use
Dr. Zahra Alsairafi,
Ph.D., MSc., M.Pharm., Clinical Lecturer, Faculty of Pharmacy, Kuwait University, Kuwait | Kuwait
"2013-2016 Doctor of Philosophy Degree (Ph.D) with (an Excellent Report for: responding to supervisors’ recommendations on schedule; and a Very Good Report for: research, writing and speaking skills). University College London (Date of Award 28 Jun. 2016) 2011-2012 Master of Science (MSc) with Merit University College London (Date of Award 1 Nov. 2012) 2004-2008 Master of Pharmacy (M.Pharm) Class 2:1 The Robert Gordon University (Date of Award 8 Jun. 2008) "


